Use of Brentuximab Vedotin in a Non-HIV Patient with Primary Effusion Lymphoma

Use of Brentuximab Vedotin in a Non-HIV Patient with Primary Effusion Lymphoma

Primary effusion lymphoma is a rare and aggressive large B-cell lymphoma presenting as malignant effusion with poor prognosis. Although it is more prevalent among HIV patients, it has also been described in non-HIV immunocompromised individuals. Given its rarity, there are no large randomized trials...

Full description

Bibliographic Details
Main Authors: Joana Ferra, Filipa Mousinho, Francisca Miranda, Sandra André, Celina Afonso, Fernando Nogueira
Format: Article
Language:English
Published: SMC MEDIA SRL 2021-02-01
Series:European Journal of Case Reports in Internal Medicine
Subjects:
primary effusion lymphoma
brentuximab vedotin
non-hiv
Online Access:https://www.ejcrim.com/index.php/EJCRIM/article/view/2345

Similar Items

Similar Items